Ma J - Search Results

1

NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.

Zhang L, Li R, Shi W, Liang X, Liu S, Ye Z, Yu C, Chen Y, Zhang B, Wang W, Lai Y, Ma J, Li Z, Tan X. Zhang L, et al. Among authors: ma j. Br J Pharmacol. 2013 Sep;170(2):426-39. doi: 10.1111/bph.12292. Br J Pharmacol. 2013. PMID: 23826864 Free PMC article.

2

[Risk factors of hypertension in IgA nephropathy].

Li SH, Shi W, Wang WJ, Liang XL, Liu SX, Ye ZM, Zhang B, He CS, Xia YF, Ma JC. Li SH, et al. Zhonghua Nei Ke Za Zhi. 2008 Nov;47(11):893-6. Zhonghua Nei Ke Za Zhi. 2008. PMID: 19080227 Chinese.

3

[A comparative study of the clinicopathological features in patients with IgA nephropathy with elevated uric acid level].

Li SH, Shi W, Xia YF, Liang XL, Wang WJ, Ma JC, Wu D. Li SH, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jan;30(1):133-6. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 20118003 Chinese.

4

Cellulose triacetate dialyzer reduces platelet loss during continuous veno-venous hemofiltration.

Liu S, Shi W, Liang X, Su Y, Liang Y, Zhang B, Ye Z, Xu L, Xia Y, He C, Ma J, Tao Y, Ye H, Li H. Liu S, et al. Among authors: ma j. Blood Purif. 2010;29(4):375-82. doi: 10.1159/000314649. Epub 2010 May 20. Blood Purif. 2010. PMID: 20484898 Clinical Trial.

5

Deletion of scavenger receptor A protects mice from progressive nephropathy independent of lipid control during diet-induced hyperlipidemia.

Wang W, He B, Shi W, Liang X, Ma J, Shan Z, Hu Z, Danesh FR. Wang W, et al. Among authors: ma j. Kidney Int. 2012 May;81(10):1002-1014. doi: 10.1038/ki.2011.457. Epub 2012 Feb 29. Kidney Int. 2012. PMID: 22377830 Free PMC article.

6

Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury.

Liu S, Shi W, Xiao H, Liang X, Deng C, Ye Z, Mei P, Wang S, Liu X, Shan Z, Liang Y, Zhang B, Wang W, Liu Y, Xu L, Xia Y, Ma J, Li Z. Liu S, et al. Among authors: ma j. PLoS One. 2012;7(7):e41331. doi: 10.1371/journal.pone.0041331. Epub 2012 Jul 25. PLoS One. 2012. PMID: 22848465 Free PMC article. Clinical Trial.

7

1,25-dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuria.

Ma J, Zhang B, Liu S, Xie S, Yang Y, Ma J, Deng Y, Wang W, Xu L, Li R, Zhang L, Yu C, Shi W. Ma J, et al. PLoS One. 2013 May 31;8(5):e64912. doi: 10.1371/journal.pone.0064912. Print 2013. PLoS One. 2013. PMID: 23741418 Free PMC article.

8

[Renal expression of RANK-RANKL in a rat model of puromycin aminonucleoside nephropathy].

Feng Z, Liu S, Shi W, Xiao H, Liang X, Liu X, Ye Z, Wang S, Liang Y, Zhang B, Wang W, Liu Y, Mei P, Xu L, Ma J, Xia Y. Feng Z, et al. Among authors: ma j. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jan;34(1):65-9. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 24463119 Chinese.

9

Urinary messenger RNA of the receptor activator of NF-kappaB could be used to differentiate between minimal change disease and membranous nephropathy.

Liu S, Mei P, Shi W, Zhang B, Li S, Liang X, Ye Z, Xu L, Ma J, Li Z, Zhang L, Wang W, Wang L, Li R, Feng Z, Dong W, Tao Y. Liu S, et al. Among authors: ma j. Biomarkers. 2014 Nov;19(7):597-603. doi: 10.3109/1354750X.2014.956148. Epub 2014 Aug 29. Biomarkers. 2014. PMID: 25171769

10

Spironolactone inhibits podocyte motility via decreasing integrin β1 and increasing integrin β3 in podocytes under high-glucose conditions.

Li Z, Zhang L, Shi W, Chen Y, Zhang H, Liu S, Liang X, Ling T, Yu C, Huang Z, Tan X, Zhao X, Ye Z, Zhang B, Wang W, Li R, Ma J. Li Z, et al. Among authors: ma j. Mol Med Rep. 2015 Nov;12(5):6849-54. doi: 10.3892/mmr.2015.4295. Epub 2015 Sep 7. Mol Med Rep. 2015. PMID: 26352002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,499 results

Search Page

Filters